← Leaderboards
Robert Carl Murphy
National Jewish Health
$18,062,548
Attributed
$18,062,548
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2005–16$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$18,062,548 · 11
By mechanism
U54$8,249,336 · 4
R01$5,608,355 · 3
P01$3,845,957 · 3
S10$358,900 · 1
Top collaborators
No co-investigators on record.
Most similar at National Jewish Health
Same institution · by research overlap
- Christina Carroll Leslie$11,280,080
- Erwin William Gelfand$9,695,720
- Richard J Martin$13,509,122
- Nathan Rabinovitch$785,103
- Mario Lacouture$1,025,459
Others in their field
Top investigators on “Lipids”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Alan M Fogelman · University Of California Los Angeles$57,458,120
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Adrian Hernandez · Duke University$50,769,596
- Garret A Fitzgerald · University Of Pennsylvania$50,340,498
- Richard A Gibbs · Baylor College Of Medicine$49,140,324
Research focus
LipidsCellsTissuesPhospholipidsMacrophageBaseProgramsEicosanoidsMetabolismMolecularMass SpectrometryAreaHuman SubjectLeukotrienesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationFatty AcidsPathway InteractionsDetectionComplexInvestigationMass Spectrum AnalysisGrantImageResolution
Grant awards (49)
High Throughput Lipidomics Analysis by MALDI/Ion Mobility Mass Spectrometry$373,781
R01 · FY2016 · ES · contact PI
High Throughput Lipidomics Analysis by MALDI/Ion Mobility Mass Spectrometry$373,781
R01 · FY2015 · ES · contact PI
High Throughput Lipidomics Analysis by MALDI/Ion Mobility Mass Spectrometry$372,891
R01 · FY2014 · ES · contact PI
High Throughput Lipidomics Analysis by MALDI/Ion Mobility Mass Spectrometry$360,839
R01 · FY2013 · ES · contact PI
GLYCEROLIPIDS$460,349
U54 · FY2012 · GM · contact PI
Bridge C(A): LIPID IMAGING$460,348
U54 · FY2012 · GM · contact PI
High Throughput Lipidomics Analysis by MALDI/Ion Mobility Mass Spectrometry$387,116
R01 · FY2012 · ES · contact PI
GLYCEROLIPIDS$451,816
U54 · FY2011 · GM · contact PI
Bridge C(A): LIPID IMAGING$451,816
U54 · FY2011 · GM · contact PI
Leukotrienes and Slow Reacting Substance of Anaphylaxis$344,340
R01 · FY2011 · HL · contact PI
Bridge C(A): LIPID IMAGING$465,052
U54 · FY2010 · GM · contact PI
GLYCEROLIPIDS$465,051
U54 · FY2010 · GM · contact PI
Lipid Tandem Quadrupole Mass Spectrometer$358,900
S10 · FY2010 · RR · contact PI
Leukotrienes and Slow Reacting Substance of Anaphylaxis$344,340
R01 · FY2010 · HL · contact PI
Bioactive lipid mediators and reactive oxygen species$735,571
P01 · FY2009 · HL · contact PI
Bridge C(A): LIPID IMAGING$468,690
U54 · FY2009 · GM · contact PI
GLYCEROLIPIDS$468,690
U54 · FY2009 · GM · contact PI
Leukotrienes and Slow Reacting Substance of Anaphylaxis$344,070
R01 · FY2009 · HL · contact PI
Bioactive lipid mediators and reactive oxygen species$669,240
P01 · FY2008 · HL · contact PI
GLYCEROLIPIDS$480,886
U54 · FY2008 · GM · contact PI
Bridge C(A): LIPID IMAGING$480,885
U54 · FY2008 · GM · contact PI
Leukotrienes and Slow Reacting Substance of Anaphylaxis$343,800
R01 · FY2008 · HL · contact PI
Bioactive lipid mediators and reactive oxygen species$551,873
P01 · FY2007 · HL · contact PI
CORE E: Novel Detection Technique Development$405,188
U54 · FY2007 · GM · contact PI
Leukotrienes and Slow Reacting Substance of Anaphylaxis$337,806
R01 · FY2007 · HL · contact PI
BRIDGE C--LC/Mass Spectrometric Analysis/Neutral Lipids$254,875
U54 · FY2007 · GM · contact PI
Bioactive lipid mediators and reactive oxygen species$348,389
P01 · FY2006 · HL · contact PI
CORE E: Novel Detection Technique Development$328,835
U54 · FY2006 · GM · contact PI
BRIDGE C--LC/Mass Spectrometric Analysis/Neutral Lipids$208,173
U54 · FY2006 · GM · contact PI
Bioactive lipid mediators and reactive oxygen species$372,793
P01 · FY2005 · HL
LEUKOTRIENES AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS$346,500
R01 · FY2005 · HL
CORE E: Novel Detection Technique Development$319,618
U54 · FY2005 · GM
EOSINOPHILS, EICOSANOID BIOSYNTHESIS AND METABOLISM$264,498
P01 · FY2005 · HL
BRIDGE C--LC/Mass Spectrometric Analysis/Neutral Lipids$203,654
U54 · FY2005 · GM
BRIDGE C--LC/Mass Spectrometric Analysis/Neutral Lipids$698,564
U54 · FY2004 · GM
LEUKOTRIENES AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS$346,500
R01 · FY2004 · HL
CORE E: Novel Detection Technique Development$310,710
U54 · FY2004 · GM
CORE E: Novel Detection Technique Development$631,151
U54 · FY2003 · GM
LEUKOTRIENES AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS$342,225
R01 · FY2003 · HL
BRIDGE C--LC/Mass Spectrometric Analysis/Neutral Lipids$234,985
U54 · FY2003 · GM
LEUKOTRIENES AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS$326,038
R01 · FY2002 · HL
EOSINOPHILS, EICOSANOID BIOSYNTHESIS AND METABOLISM$242,054
P01 · FY2002 · HL
Isoeicosanoids&Biologically Active Oxidized Phospholipi$220,513
P01 · FY2002 · HL
LEUKOTRIENES AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS$287,263
R01 · FY2001 · HL
Isoeicosanoids&Biologically Active Oxidized Phospholipi$220,513
P01 · FY2001 · HL
EOSINOPHIL, EICOSANOID, BIOSYNTHESIS AND METABOLISM$96,097
R01 · FY2001 · HL
EOSINOPHILS, EICOSANOID BIOSYNTHESIS AND METABOLISM$0
P01 · FY2001 · HL
LEUKOTRIENES AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS$280,968
R01 · FY2000 · HL
Isoeicosanoids&Biologically Active Oxidized Phospholipi$220,513
P01 · FY2000 · HL